Off Clamp Randomization

Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors

The purpose of this research study is to compare the effects on kidney function after performing the removal of a kidney tumor with or without clamping the blood vessels during surgery.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients 18 and older.
  • Patients willing and able to sign consent.
  • Patients with an organ confined renal mass planning to undergo a robotic assisted partial nephrectomy (RAPN).
  • Patient with Karnofsky Performance Status (KPS) equal to or greater than 40.

Exclusion Criteria:

  • Patients under 18.
  • Patients with Karnofsky Performance Status (KPS) less than 40.
  • Patients with non-organ confined renal masses (invading renal vein, inferior vena cava, peri-renal tissue, ipsilateral adrenal gland, or metastasis).
  • Patients with bilateral synchronous renal masses.
  • Patients who can not discontinue Plavix, Coumadin or other anti-platelet or anti-coagulant medications.
  • Patients with renal lesions determined to be too complex to perform a RAPN without clamp by the surgeon. (The renal mass may be deemed too difficult based on pre-operatively radiological findings. The surgeon's decision to exclude a mass from a robotic assisted partial nephrectomy would be based on a higher risk of positive margin or complication if a RAPN was performed.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Off-clamp partial nephrectomy
Partial nephrectomy will be performed without clamping of the renal blood vessels.
No Intervention: Traditional partial nephrectomy
Partial nephrectomy will be performed with clamping of the renal blood vessels.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent Change From Baseline in eGFR
Time Frame: baseline and 3 months post nephrectomy
Renal function following nephrectomy with and without clamping will be assessed using: percent change in eGFR from baseline to 3 months post nephrectomy.
baseline and 3 months post nephrectomy
Percent Change From Baseline in Split Renal Function
Time Frame: baseline to 3 months post nephrectomy
Renal function following nephrectomy with and without clamping will be assessed using: percent change in split renal function from baseline to 3 months post nephrectomy.
baseline to 3 months post nephrectomy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent of Observations With Positive Surgical Margins.
Time Frame: at the time of nephrectomy
Oncologic outcomes will be assessed at the time of nephrectomy based on percent of observations with positive surgical margins.
at the time of nephrectomy
Estimated Blood Loss
Time Frame: At the time of nephrectomy
Perioperative outcomes will be assessed based on estimated blood loss at the time of nephrectomy.
At the time of nephrectomy
Percent of Observations With Metastasis
Time Frame: 3 years
Oncologic outcomes will be assessed based on percent of observations with metastasis on follow-up imaging at 3 years post nephrectomy.
3 years
Operative Time Measured in Minutes.
Time Frame: At the time of nephrectomy
Perioperative outcomes will be assessed based on operative time measured in minutes at the time of nephrectomy.
At the time of nephrectomy
Warm Ischemia Time Measured in Minutes.
Time Frame: At the time of nephrectomy.
Perioperative outcomes will be assessed based on warm ischemia time measured in minutes at the time of nephrectomy.
At the time of nephrectomy.
Percent of Observations With Intra-operative Complications.
Time Frame: At the time of nephrectomy
Perioperative outcomes will be assessed based on percent of observations with intra-operative complications at the time of nephrectomy.
At the time of nephrectomy
Number of Hospital Days Post Nephrectomy.
Time Frame: Day of nephrectomy to day of hospital discharge.
Perioperative outcomes will be assessed based number of hospital days post nephrectomy.
Day of nephrectomy to day of hospital discharge.
Percent of Observations With Postoperative Complications.
Time Frame: Within 3 months post nephrectomy.
Perioperative outcomes will be assessed based on percent of observations with postoperative complications.
Within 3 months post nephrectomy.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Robert S Figenshau, MD, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

May 31, 2017

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

November 16, 2012

First Submitted That Met QC Criteria

November 21, 2012

First Posted (Estimate)

November 22, 2012

Study Record Updates

Last Update Posted (Actual)

May 19, 2023

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe